Our results also indicate that upregulated miRNAs like miR-192-5p could be upregulated in early-stage HBV infection [100,101], as well as in later stage HBV-HCC serum targeting XIAP/TRIM44, SEMA3A and FABP3/YY1/PABPC4 [29,30]. Here, SEMA3A is linked to hepatocellular carcinoma.